Research and Medical Chemicals Group reinforces management structure 

Nico Aelmans (Group CEO) is pleased to announce that in order to cater for growth Research and Medical Chemicals Group (RMC) of which Buchem BV is an integral part has reinforced the management structure by following nominations as per 1st February 2022.

Johan Leugs will assume the responsibility of Chief Operating Officer

Luc Amkreutz has been appointed Chief Financial Officer

Casper (John) Frijns will support the group as Chief Marketing and Sales Officer

With these appointments RMC will be able to further drive the integration of Buchem’s sister companies Reseachem GmbH and Swant AG as well as preparing the ground for further acquisitions.

Please contact us for more information.